Cancer Network: Peer Influence Impacts the Adoption of High-Value Cancer Treatments Over Time

By Damon Centola “Oncologists’ adoption and use of bevacizumab (Avastin) in the years after its approval was greater if their peer physicians were earlier adopters, according to an investigation published in JAMA Network Open. As organizations continue to strive toward better care at lower costs, interventions that influence physician ties may help to promote adoption of high-value use of new cancer treatments and unemployment of low-value therapies.” Read more at Cancer Network, Cure Today, and Cancer Therapy Advisor